Skip to main content
. 2021 Feb 19;11:623792. doi: 10.3389/fendo.2020.623792

Table 2.

Clinical characteristics and selected laboratory abnormalities of COVID-19 patients with and without thyroid dysfunction.

Thyroid dysfunction* (N = 52) Mean ± SD or n (%) Normal (N = 32) Mean ± SD or n (%) P value
Gender
Male 35 (66.0%) 18 (34.0%) 0.308
Female 17 (54.8%) 14 (45.2%)
Clinical classifications on admission
Mild and moderate 5 (23.8%) 16 (76.2%) 0.000
Severe and critical 47 (74.6%) 16 (25.4%)
Viral nucleic acid cleaning time (days) 14.1 ± 9.4 10.6 ± 8.3 0.088
Thyroid auto-antibodies
TPOAb (IU/ml, normal range 0–5.61) 23.95 ± 38.12 24.71 ± 57.08 0.945
TGAb (IU/ml, normal range 0–4.11) 35.05 ± 142.01 20.98 ± 47.31 0.613
Cytokines
IL-6 (pg/ml; normal range 0–6.61) 59.27 ± 98.24 51.99 ± 95.17 0.748
IL-10 (pg/ml; normal range 0–2.31) 8.15 ± 10.92 6.11 ± 7.58 0.378
TNF-α (pg/ml; normal range 0–33.27) 69.14 ± 259.33 31.27 ± 38.23 0.438
IFN-γ (pg/ml; normal range 0–20.06) 32.92 ± 73.10 30.92 ± 47.39 0.895
Blood routine tests
Leucocytes (x109/L; normal range 4–10) 8.71 ± 5.33 4.92 ± 1.64 0.000
Neutrophils (x109/L; normal range 2–7) 7.97 ± 5.30 3.40 ± 1.51 0.000
Lymphocytes (x109/L; normal range 0.8–4) 0.62 ± 0.33 1.09 ± 0.41 0.000
Platelets (x109/L; normal range 83–303) 189.13 ± 71.13 209.38 ± 75.93 0.221
Haemoglobin
(g/L; normal range: male 131–172, female 113–151)
132.50 ± 17.14 137.16 ± 15.69 0.216
Infection-related biomarkers
Procalcitonin (ng/L; normal range 0–0.5) 0.22 ± 0.46 0.06 ± 0.45 0.054
C reactive protein (mg/ml; normal range 0–8) 38.14 ± 37.01 15.60 ± 17.73 0.002
Blood biochemistry
Globulin (g/L; normal range 20–40) 29.34 ± 5.85 27.82 ± 4.16 0.204

TPOAb, thyroid peroxidase antibody; TGAb, thyroglobulin antibody; IL-6, interleukin-6; IL-10, interleukin-10; TNF-α, tumor necrosis factor α; IFN-γ, interferon-γ.

p value in bold was regarded as statistically significant.

*Thyroid dysfunction indicates any abnormalities in the levels of TT4, TT3, or TSH.